Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Nature Communications
|
September 25, 2021
Bioengineered 3D models of human pancreatic cancer recapitulate in vivo tumour biology
David Osuna de la Peña, Sara Maria David Trabulo, Estelle Collin, et al.
Cancers
|
December 23, 2023
Establishment and Thorough Characterization of Xenograft (PDX) Models Derived from Patients with Pancreatic Cancer for Molecular Analyses and Chemosensitivity Testing
Diana Behrens, Ulrike Pfohl, Theresia Conrad, et al.
Nature Communications
|
December 22, 2020
The epigenetic regulator Mll1 is required for Wnt-driven intestinal tumorigenesis and cancer stemness
Johanna Grinat, Julian Heuberger, Ramon Oliveira Vidal, et al.
Cell Death Discovery
|
March 21, 2020
TFEB-mediated lysosomal biogenesis and lysosomal drug sequestration confer resistance to MEK inhibition in pancreatic cancer
Ben Zhao, Laura Dierichs, Jiang-Ning Gu, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 28, 2023
Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity
Quan Zheng, Jiajia Tang, Alexandra Aicher, et al.
Scientific Reports
|
March 13, 2019
Human melanoma brain metastases cell line MUG-Mel1, isolated clones and their detailed characterization
Ellen Heitzer, Arwin Groenewoud, Katharina Meditz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 8, 2016
Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ERCC3-MYC Interactions as a Target in Pancreatic Cancer
Natalya Beglyarova, Eugenia Banina, Yan Zhou, et al.
Clinical Epigenetics
|
January 16, 2024
Pancreatic cancer acquires resistance to MAPK pathway inhibition by clonal expansion and adaptive DNA hypermethylation
Laura K Godfrey, Jan Forster, Sven-Thorsten Liffers, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
September 24, 2024
Microfluidic formulation, cryoprotection and long-term stability of paclitaxel-loaded π electron-stabilized polymeric micelles
Rahaf Mihyar, Armin Azadkhah Shalmani, Viktor Wildt, et al.
Nature Communications
|
December 3, 2024
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer
Lisa Veghini, Davide Pasini, Rui Fang, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Nature Communications
|
September 25, 2021
Bioengineered 3D models of human pancreatic cancer recapitulate in vivo tumour biology
David Osuna de la Peña, Sara Maria David Trabulo, Estelle Collin, et al.
Cancers
|
December 23, 2023
Establishment and Thorough Characterization of Xenograft (PDX) Models Derived from Patients with Pancreatic Cancer for Molecular Analyses and Chemosensitivity Testing
Diana Behrens, Ulrike Pfohl, Theresia Conrad, et al.
Nature Communications
|
December 22, 2020
The epigenetic regulator Mll1 is required for Wnt-driven intestinal tumorigenesis and cancer stemness
Johanna Grinat, Julian Heuberger, Ramon Oliveira Vidal, et al.
Cell Death Discovery
|
March 21, 2020
TFEB-mediated lysosomal biogenesis and lysosomal drug sequestration confer resistance to MEK inhibition in pancreatic cancer
Ben Zhao, Laura Dierichs, Jiang-Ning Gu, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 28, 2023
Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity
Quan Zheng, Jiajia Tang, Alexandra Aicher, et al.
Scientific Reports
|
March 13, 2019
Human melanoma brain metastases cell line MUG-Mel1, isolated clones and their detailed characterization
Ellen Heitzer, Arwin Groenewoud, Katharina Meditz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 8, 2016
Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ERCC3-MYC Interactions as a Target in Pancreatic Cancer
Natalya Beglyarova, Eugenia Banina, Yan Zhou, et al.
Clinical Epigenetics
|
January 16, 2024
Pancreatic cancer acquires resistance to MAPK pathway inhibition by clonal expansion and adaptive DNA hypermethylation
Laura K Godfrey, Jan Forster, Sven-Thorsten Liffers, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
September 24, 2024
Microfluidic formulation, cryoprotection and long-term stability of paclitaxel-loaded π electron-stabilized polymeric micelles
Rahaf Mihyar, Armin Azadkhah Shalmani, Viktor Wildt, et al.
Nature Communications
|
December 3, 2024
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer
Lisa Veghini, Davide Pasini, Rui Fang, et al.
Page
of 3